Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients
Section snippets
Acknowledgments
We thank Drs Ulf Pettersson and Lars Lannfelt for critically reviewing this manuscript. We also wish to thank the anonymous reviewers for valuable comments, and the Brain Bank Department of Neuropathology, Institute of Psychiatry, King's college London, SES 8AF, United Kingdom for providing the brain autopsies. This work was supported by the Swedish Medical Research Council, the Beijer Foundation and the Göran Gustavsson Foundation.
References (14)
- et al.
Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development
Prog. Neuropsychopharmacol. Biol. Psychiatry
(2001) - et al.
Monoamine oxidase B in brains from patients with Alzheimer's disease: a biochemical and autoradiographical study
Neuroscience
(1991) - et al.
Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity
J. Struct. Biol.
(2000) - et al.
Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide
Neurosci. Lett.
(2001) - et al.
Molecular characterization of monoamine oxidases A and B
Prog. Nucleic Acid Res. Mol. Biol.
(2000) - et al.
High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies
Genome Res.
(2000) - et al.
Tissue distribution of human monoamine oxidase A and B mRNA
J. Neurochem.
(1990)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2002 Published by Elsevier Ireland Ltd.